Skip to content

Management Of Timira - Immature Senile Cataract - A Randomized Controlled Clinical Trial

Efficacy Of Chandrodaya Varti Anjana Along With Timirahara Lauha Orally In The Management Of Timira - Immature Senile Cataract - A Randomized Controlled Clinical Trial - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063455
Enrollment
85
Registered
2024-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 patients having signs and symptoms of immature senile cataract described as per ayurvedic and contemporary texts 2 patients willing to take ayurvedic treatment 3 Visual Acuity better than or equal to 6/60 Snellen chart/ Log MAR 1 4 Senile immature cataract

Exclusion criteria

Exclusion criteria: 1 Congenital cataract,Traumatic cataract 2 Patients suffering from inflammatory and infectious disease of eyeball and its appendages 3 Hyper-mature and mature cataract 4 Patients is under / having history of using any cataract inducing medications like corticosteroids, phenothiazines and miotics drugs etc 5 History of any surgical intervention to eye 6 Patients having other systemic diseases or metabolic disorders or ocular diseases such as uncontrolled D.M., Diabetic Retinopathy, Macular Degeneration, Retinitis Pigmentosa and any other illness necessitating long term treatment or under any kind of immunosuppressive therapy

Design outcomes

Primary

MeasureTime frame
Improvement of Avyakta Darshana (blurring of vision) in terms of Visual acuityTimepoint: 90 days

Secondary

MeasureTime frame
Assessment of Ocular toxicity of Chandodaya Varti Anjana improvement of other associated symptoms like glare, diplopia, black spots in front of eyes, difficulty in day and night vision, headache Timepoint: 90 days

Countries

India

Contacts

Public ContactDr Sangita Shekhaliya

All India Institute Of Ayurveda

eyenimi@gmail.com9650715615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026